» Authors » David Korones

David Korones

Explore the profile of David Korones including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 104
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson M, Silberstein H, Korones D, Hussain A, Hawes D
Surg Neurol Int . 2024 Feb; 15:14. PMID: 38344090
Background: Low-grade fibromyxoid tumors are uncommon in children. Their differentiation from high-grade fibromyxoid tumors, as seen in adults, is imperative to diagnosis. Awareness of the entity and its subsequent behavior...
2.
Buhlinger K, Borlagdan J, Agegnehu B, Fentie A, Bernstein A, Urick B, et al.
J Oncol Pharm Pract . 2020 Dec; 27(8):1940-1947. PMID: 33342356
In Ethiopia, cancer accounts for about 5.8% of total national mortality, with an estimated annual incidence of cancer of approximately 60,960 cases and an annual mortality of over 44,000 persons....
3.
Fentie A, Buhlinger K, Borlagdan J, Bernstein A, Weitzman S, Bekele W, et al.
Blood Adv . 2019 Dec; 3(Suppl 1):16-19. PMID: 31809541
No abstract available.
4.
Chi A, Tarapore R, Hall M, Shonka N, Gardner S, Umemura Y, et al.
J Neurooncol . 2019 Aug; 145(1):97-105. PMID: 31456142
Background: H3 K27M-mutant diffuse midline glioma is a fatal malignancy with no proven medical therapies. The entity predominantly occurs in children and young adults. ONC201 is a small molecule selective...
5.
Johnson M, OConnell M, Silberstein H, Korones D
Appl Immunohistochem Mol Morphol . 2013 Mar; 21(6):532-8. PMID: 23455179
Recently, somatostatin receptors (SSR) have been identified on medulloblastomas and proposed as a new target for chemotherapy including inhibitory somatostatin analogs. Activation of SSRs inhibit growth, in part, by activating...